"The company has received World Health Organization (WHO) prequalification for the product Sulfadoxine," says the Mumbai-based pharma company in its filing to the exchange.
first published: Dec 17, 2015 10:36 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
You are already a Moneycontrol Pro user.

